share_log

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd's (SHSE:603976) Stock Price Dropped 18% Last Week; Private Companies Would Not Be Happy

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd's (SHSE:603976) Stock Price Dropped 18% Last Week; Private Companies Would Not Be Happy

重慶正川藥用包裝有限公司, Ltd(SHSE: 603976)的股價上週下跌了18%;私營公司不會感到高興
Simply Wall St ·  04/17 08:16

Key Insights

關鍵見解

  • Significant control over ChongQing Zhengchuan Pharmaceutical PackagingLtd by private companies implies that the general public has more power to influence management and governance-related decisions
  • The top 2 shareholders own 67% of the company
  • Insiders own 33% of ChongQing Zhengchuan Pharmaceutical PackagingLtd
  • 私營公司對重慶正川藥品包裝有限公司的重大控制意味着公衆擁有更大的影響管理和治理相關決策的權力
  • 前兩名股東擁有公司67%的股份
  • 業內人士持有重慶正川醫藥包裝有限公司 33% 的股份

To get a sense of who is truly in control of ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd (SHSE:603976), it is important to understand the ownership structure of the business. We can see that private companies own the lion's share in the company with 39% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

了解誰真正控制了重慶正川藥品包裝有限公司, Ltd(上海證券交易所代碼:603976),了解企業的所有權結構很重要。我們可以看到,私營公司擁有該公司的大部分股份,所有權爲39%。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。

While the holdings of private companies took a hit after last week's 18% price drop, insiders with their 33% also suffered.

儘管在上週股價下跌18%之後,私營公司的持股量受到打擊,但33%的內部人士也遭受了損失。

In the chart below, we zoom in on the different ownership groups of ChongQing Zhengchuan Pharmaceutical PackagingLtd.

在下圖中,我們放大了重慶正川醫藥包裝有限公司的不同所有權組。

ownership-breakdown
SHSE:603976 Ownership Breakdown April 17th 2024
SHSE: 603976 所有權明細 2024 年 4 月 17 日

What Does The Lack Of Institutional Ownership Tell Us About ChongQing Zhengchuan Pharmaceutical PackagingLtd?

關於重慶正川醫藥包裝有限公司,缺乏機構所有權告訴我們什麼?

Institutional investors often avoid companies that are too small, too illiquid or too risky for their tastes. But it's unusual to see larger companies without any institutional investors.

機構投資者通常會避開規模太小、流動性太差或風險太大的公司,不符合他們的口味。但是,看到沒有任何機構投資者的大型公司是不尋常的。

There are multiple explanations for why institutions don't own a stock. The most common is that the company is too small relative to funds under management, so the institution does not bother to look closely at the company. It is also possible that fund managers don't own the stock because they aren't convinced it will perform well. ChongQing Zhengchuan Pharmaceutical PackagingLtd's earnings and revenue track record (below) may not be compelling to institutional investors -- or they simply might not have looked at the business closely.

機構爲何不擁有股票,有多種解釋。最常見的情況是,公司相對於所管理的資金來說規模太小,因此該機構不願仔細研究該公司。基金經理也可能不擁有這隻股票,因爲他們不相信股票會表現良好。重慶正川醫藥包裝有限公司的收益和收入記錄(見下文)可能不會吸引機構投資者,或者他們可能根本沒有仔細研究該業務。

earnings-and-revenue-growth
SHSE:603976 Earnings and Revenue Growth April 17th 2024
SHSE: 603976 2024 年 4 月 17 日收益和收入增長

ChongQing Zhengchuan Pharmaceutical PackagingLtd is not owned by hedge funds. Our data shows that Chongqing Zhengchuan Investment Management Co., Ltd. is the largest shareholder with 39% of shares outstanding. In comparison, the second and third largest shareholders hold about 28% and 3.2% of the stock. Yong Deng, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.

重慶正川醫藥包裝有限公司不歸對沖基金所有。我們的數據顯示,重慶正川投資管理有限公司是最大股東,已發行股份的39%。相比之下,第二和第三大股東持有約28%和3.2%的股份。作爲第二大股東的鄧勇也恰好擁有首席執行官的頭銜。

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

在進一步挖掘之後,我們發現前兩位股東共同控制了公司一半以上的股份,這意味着他們擁有影響公司決策的巨大權力。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

雖然研究公司的機構所有權數據是有意義的,但研究分析師的情緒以了解風向哪個方向吹來也是有意義的。我們目前沒有收到分析師對該股的任何報道,因此該公司不太可能被廣泛持有。

Insider Ownership Of ChongQing Zhengchuan Pharmaceutical PackagingLtd

重慶正川醫藥包裝有限公司的內部所有權

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間確實有所不同。我們的數據反映了個人內部人士,至少涵蓋了董事會成員。公司管理層經營業務,但首席執行官將對董事會負責,即使他或她是董事會成員。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲這可能表明董事會與其他股東關係良好。但是,在某些情況下,過多的權力集中在該群體中。

Our information suggests that insiders maintain a significant holding in ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. Insiders have a CN¥698m stake in this CN¥2.1b business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

我們的信息表明,內部人士持有重慶正川藥用包裝有限公司的大量股份。, Ltd. 內部人士在這項21億元人民幣的業務中持有6.98億元人民幣的股份。很高興看到內部人士對這項業務進行如此投資。可能值得檢查一下這些內部人士最近是否在買入。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 28% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

包括散戶投資者在內的公衆擁有該公司28%的股份,因此不容忽視。這種所有權規模雖然可觀,但如果決策與其他大股東不同步,可能不足以改變公司政策。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 39%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們的數據表明,私人公司持有該公司39%的股份。僅憑這一事實很難得出任何結論,因此值得研究誰擁有這些私營公司。有時,內部人士或其他關聯方通過獨立的私人公司持有上市公司的股份權益。

Next Steps:

後續步驟:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - ChongQing Zhengchuan Pharmaceutical PackagingLtd has 3 warning signs (and 1 which doesn't sit too well with us) we think you should know about.

儘管值得考慮擁有公司的不同群體,但還有其他因素更爲重要。舉個風險吧——重慶正川醫藥包裝有限公司有 3 個警示標誌(其中一個不太適合我們)我們認爲你應該知道。

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

當然,這可能不是最值得買入的股票。因此,來看看這份免費的有趣公司名單吧。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論